DOCSLIB.ORG

(12) Patent Application Publication (10) Pub. No.: US 2012/0172429 A1 Woolf Et Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(12) Patent Application Publication (10) Pub. No.: US 2012/0172429 A1 Woolf Et Al US 2012O172429A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0172429 A1 Woolf et al. (43) Pub. Date: Jul. 5, 2012 (54) PERMANENTLY CHARGED SODUMAND Publication Classification CALCUMI CHANNEL BLOCKERS AS ANT (51) Int. Cl. NFLAMMLATORY AGENTS A 6LX 3L/277 (2006.01) C07C 237/14 (2006.01) (76) Inventors: Clifford J. Woolf, Newton, MA C07C 255/33 (2006.01) (US); Bruce P. Bean, Waban, MA A6IP 25/00 (2006.01) (US) A6IP 29/00 (2006.01) A6IP II/06 (2006.01) A6IP II/IO (2006.01) (21) Appl. No.: 13/382,834 A6IP 9/02 (2006.01) A6IP 700 (2006.01) (22) PCT Fled: Jul. 9, 2010 A6IPI/00 (2006.01) A6IPI3/02 (2006.01) (86) PCT NO.: PCT/US 10/41537 A6IP 25/06 (2006.01) A6IP 7/06 (2006.01) S371 (c)(1), A6IP II/02 (2006.01) (2), (4) Date: Mar. 26, 2012 A6II 3/16 (2006.01) (52) U.S. Cl. .......... 514/523: 514/626:564/194; 558/408 Related U.S. Application Data (57) ABSTRACT (60) Provisional application No. 61/224,512, filed on Jul. The invention provides compounds, compositions, methods, 10, 2009. and kits for the treatment of neurogenic inflammation. Patent Application Publication US 2012/0172429 A1 7Z089||Z0897ZZOZ7Z euu||(SunO?) 3.Infi!--| Patent Application Publication Jul. 5, 2012 Sheet 2 of 2 US 2012/0172429 A1 Figure 2 1 uM Capsaicin - Before - After (3 min Wash) 1 uM Capsaicin +300 uMN-methyl-verapamil After (3 min Wash) US 2012/0172429 A1 Jul. 5, 2012 PERMANENTLY CHARGED SODUMAND of a compound that is capable of entering a nociceptor CALCUMI CHANNEL BLOCKERS AS ANT through a channel-forming receptor present in the nociceptor NFLAMMLATORY AGENTS when the receptor is activated and inhibiting a Voltage-gated ion channel present in the nociceptor, wherein the compound CROSS-REFERENCE TO RELATED does not substantially inhibit said channel when applied to the APPLICATIONS extracellular face of the channel and when the receptor is not 0001. This application claims benefit of U.S. Provisional activated. In certain embodiments, the compound is an inhibi Application No. 61/224,512, filed Jul. 10, 2009, which is tor of Voltage-gated sodium channels. Exemplary inhibitors hereby incorporated by reference. of this class are QX-314, N-methyl-procaine, QX-222, N-oc tyl-guanidine, 9-aminoacridine and pancuronium. In other FIELD OF THE INVENTION embodiments, the compound is a quarternary amine deriva 0002 The invention provides compounds, methods and tive or other charged derivative of a compound selected from kits for the treatment of neurogenic inflammation. riluzole, mexilitine, phenyloin, carbamazepine, procaine, articaine, bupivicaine, mepivicaine, tocainide, prilocaine, BACKGROUND OF THE INVENTION diisopyramide, bencyclane, quinidine, bretylium, lifarizine, 0003. The invention features methods and kits for the lamotrigine, flunarizine, and fluspirilene. In other embodi treatment of neurogenic inflammation by targeting nocicep ments, the compound is an inhibitor of calcium channels. tors with drugs of low molecular weight, while minimizing Inhibitors of this class include D-890, CERM 11888, N-me effects on non-pain-sensing neurons or other types of cells. thyl-verapamil, N-methylgallopamil, N-methyl-devapamil, According to the method of the invention, Small, hydrophilic dodecyltrimethylammonium, and terpene compounds (e.g., drug molecules gain access to the intracellular compartment sesquiterpenes), as well as charged derivatives (e.g., a quar of pain-sensing neurons via entry through receptor/channels ternary amine derivative or a guanylated derivative) of Vera that are present in pain-sensing neurons but to a lesser extent pamil, gallopamil, devapamil, diltiazem, fendiline, milbe or not at all in other types of neurons or in other types of fradil, or farnesyl amine. Still other exemplary inhibitors of tissue. Neurogenic inflammation is a mode of inflammation calcium channels can be described by Formulas XI-XIV) and mediated by the efferent (motor) functions of sensory neu in Tables 1, 2, and 3. In further embodiments, the ion channel rons, in which pro-inflammatory mediator molecules inhibitor is a charged derivative (e.g., a quarternary amine released in the periphery by pain-sensing neurons (nocicep derivative or a guanylated derivative) of any of compounds tors) both activate a variety of inflammatory pathways and (1)–(563). Exemplary derivatives are described herein. also act on the vascular system to alter blood flow and capil 0008. The channel-forming receptor can be activated prior lary permeability. to administering the compound by administration of a second 0004 Neurogenic inflammation contributes to the periph compound that opens the channel. Alternatively, the channel eral inflammation elicited by tissue injury, autoimmune dis forming receptor can be activated by endogenous compounds ease, infection, exposure to irritants in a variety of tissues, and present in the patient. is thought to play an important role in the pathogenesis of 0009. The invention also features a kit that includes a numerous disorders (e.g. migraine, arthritis, rhinitis, gastritis, composition for treating neurogenic inflammation inapatient colitis, cystitis, and Sunburn). and instructions for the administration of the composition to 0005 One way to reduce neurogenic inflammation is to a patient to treat neurogenic inflammation. The composition block excitability in nociceptors, thereby preventing the acti includes a compound that is capable of entering a nociceptor Vation of nociceptor peripheral terminals and the release of through a channel-forming receptor present in the nociceptor pro-inflammatory chemicals. Local anesthetics such as when the receptor is activated and inhibiting a Voltage-gated lidocaine and articaine act by inhibiting Voltage gated ion ion channel present in the nociceptor, wherein the compound channels in neurons. Local anesthetics are relatively hydro does not substantially inhibit said channel when applied to the phobic molecules that gain access to their blocking site on the extracellular face of the channel and when the receptor is not Sodium channel by diffusing into or through the cell mem activated. In certain embodiments, the compound is an inhibi brane. However, these anesthetics block sodium or calcium tor of Voltage-gated Sodium channels or calcium channels, channels and thereby the excitability of all neurons, not just Such as those described herein. In some embodiments, the pain-sensing neurons. Thus, administration of local anesthet compound is QX-314, N-methyl-procaine, QX-222, N-octyl ics produces unwanted or deleterious effects such as general guanidine, 9-aminoacridine, pancuronium, or another low numbness from block of low threshold pressure and touch molecular weight, charged molecule that inhibits Voltage receptors, motor deficits from block of motor axons and other gated Sodium channels when present inside of said nocicep complications from block of autonomic fibers. Local anes tor. In other embodiments, the compound is D-890, CERM thetics also act on Sodium channels on Smooth muscle in the 11888, N-methyl-verapamil, N-methylgallopamil, N-me cardiovascular and respiratory systems producing deleterious thyl-devapamil, and dodecyltrimethylammonium; a quarter effects. nary amine derivative, of Verapamil, gallopamil, devapamil, 0006. Accordingly, there is a need for an approach to diltiazem, fendiline, mibefradil, or farnesyl amine; a com reducing neurogenic inflammation that selectively targets pound according to any of Formulas (XI), (XII), (XIII-A), nociceptors. (XIII-B), (XIII-C), and (XIV); or a quarternary amine deriva tive or other charged derivative of any of compounds (1)- SUMMARY OF THE INVENTION (563). 0007. In a first aspect, the invention features a method for 0010. Any of the compositions, methods, and kits of the treating neurogenic inflammation in a patient, Such as a invention may optionally feature a second compound that human, by administering a therapeutically effective amount activates the channel-forming receptor. In one embodiment, US 2012/0172429 A1 Jul. 5, 2012 the second compound activates a channel-forming receptor (URB597), amylocaine, articaine, benzocaine, bupivacaine, selected from TRPV1, P2X(2/3), TRPA1, and TRPM8. carbocaine, carticaine, chloroprocaine, cyclomethycaine, 0011 Activators of TRPV1 receptors include but are not dibucaine (cinchocaine), dimethocaine (larocaine), eti limited to capsaicin, eugenol, camphor, clotrimazole, arvanil docaine, hexylcaine, levobupivacaine, lidocaine, mepiv (N-arachidonoylvanillamine), anandamide, 2-aminoethoxy acaine, meprylcaine (oracaine), metabutoxycaine, piper diphenyl borate (2APB), AM404, resiniferatoxin, phorbol ocaine, prilocaine, procaine (novacaine), proparacaine, 12-phenylacetate 13-acetate 20-homovanillate (PPAHV), propoxycaine, risocaine, ropivacaine, tetracaine (ame olvanil (NE 19550), OLDA (N-oleoyldopamine), N-arachi donyldopamine (NADA), 6'-iodoresiniferatoxin (6'-IRTX), thocaine), and trimecaine. Other activators of TRPA1 recep C18 N-acylethanolamines, lipoxygenase derivatives such as tors are described in Taylor-Clark et al., Mol Pharmacol 12-hydroperoxyeicosatetraenoic acid, inhibitor cysteine knot (2007) PMID: 18000030; Macpherson et al., Nature (2007) (ICK) peptides (vanillotoxins), piperine, MSK195 (N-2-(3. 445:541-545; and Hillet al., J. Biol. Chem. (2007)282:7145 4-dimethylbenzyl)-3-(pivaloyloxy)propyl-2-4-(2-aminoet 7153. Still other TRPA1 activators include: femamate hoxy)-3-methoxyphenyl)acetamide), JYL79 (N-2-(3,4- NSAIDS (Hu et al., Pflugers Arch. 459(4):579-92 (2010)), dimethylbenzyl)-3-(pivaloyloxy)propyl-N'-(4-hydroxy-3-
Load more

Recommended publications
  • Capsicum Oleoresin and Homocapsaicin
    Printed on: Wed Jan 06 2021, 02:44:36 AM Official Status: Currently Official on 06-Jan-2021 DocId: 1_GUID-1560FD9B-BE0F-495E-9994-C5718733DB4C_2_en-US (EST) Printed by: Jinjiang Yang Official Date: Official as of 01-May-2019 Document Type: USP @2021 USPC 1 nordihydrocapsaicin, nonivamide, decanylvanillinamide, Capsicum Oleoresin and homocapsaicin. DEFINITION ASSAY Capsicum Oleoresin is an alcoholic extract of the dried ripe · CONTENT OF TOTAL CAPSAICINOIDS fruits of Capsicum. It contains NLT 6.5% of total Mobile phase: A mixture of acetonitrile and diluted capsaicinoids, calculated as the sum of capsaicin, phosphoric acid (1 in 1000) (2:3) dihydrocapsaicin, nordihydrocapsaicin, nonivamide, Standard solution A: 0.2 mg/mL of USP Capsaicin RS in decanylvanillinamide, and homocapsaicin, all calculated on methanol the anhydrous basis. The nonivamide content is NMT 5% of Standard solution B: 0.1 mg/mL of USP the total capsaicinoids, calculated on the anhydrous basis. Dihydrocapsaicin RS in methanol [CAUTIONÐCapsicum Oleoresin is a powerful irritant, and Sample solution: 5 mg/mL of Capsicum Oleoresin in even in minute quantities produces an intense burning methanol. Pass a portion of this solution through a filter of sensation when it comes in contact with the eyes and 0.2-µm pore size, and use the filtrate as the Sample solution. tender parts of the skin. Care should be taken to protect Chromatographic system the eyes and to prevent contact of the skin with (See Chromatography á621ñ, System Suitability.) Capsicum Oleoresin.] Mode: LC IDENTIFICATION
    [Show full text]
  • Solid Solution Compositions and Use in Chronic Inflammation
    (19) *EP003578172A1* (11) EP 3 578 172 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 11.12.2019 Bulletin 2019/50 A61K 9/14 (2006.01) A61K 47/14 (2017.01) A61K 47/44 (2017.01) A61K 31/12 (2006.01) (2006.01) (2006.01) (21) Application number: 19188174.7 A61K 31/137 A61K 31/167 A61K 31/192 (2006.01) A61K 31/216 (2006.01) (2006.01) (2006.01) (22) Date of filing: 14.01.2014 A61K 31/357 A61K 31/366 A61K 31/4178 (2006.01) A61K 31/4184 (2006.01) A61K 31/522 (2006.01) A61K 31/616 (2006.01) A61K 31/196 (2006.01) (84) Designated Contracting States: • BREW, John AL AT BE BG CH CY CZ DE DK EE ES FI FR GB London, Greater London EC2Y 8AD (GB) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO • REILEY, Richard Robert PL PT RO RS SE SI SK SM TR London, Greater London EC2Y 8AD (GB) • CAPARRÓS-WANDERLEY, Wilson (30) Priority: 14.01.2013 US 201361752356 P London, Greater London EC2Y 8AD (GB) 04.02.2013 US 201361752309 P (74) Representative: Clements, Andrew Russell Niel et (62) Document number(s) of the earlier application(s) in al accordance with Art. 76 EPC: Schlich 14702460.8 / 2 925 367 9 St Catherine’s Road Littlehampton, West Sussex BN17 5HS (GB) (71) Applicant: InFirst Healthcare Limited London EC2Y 8AD (GB) Remarks: This application was filed on 24-07-2019 as a (72) Inventors: divisional application to the application mentioned • BANNISTER, Robin Mark under INID code 62.
    [Show full text]
  • Extensive Exposure to Tear Gases in Ankara
    Turk Thorac J 2019 DOI: 10.5152/TurkThoracJ.2018.18096 Original Article Extensive Exposure to Tear Gases in Ankara Aslıhan Ilgaz1 , Filiz Çağla Küçük Uyanusta2 , Peri Arbak3 , Arif Müezzinoğlu4 , Tansu Ulukavak Çiftçi5 , Serdar Akpınar6 , Hikmet Fırat6 , Selma Fırat Güven7 , Bülent Çiftçi8 , Selen Karaoğlanoğlu9 , Elif Dağlı10 , Feyza Erkan11 1Clinic of Pulmonary Diseases, Middle East Technical University, Medical Center, Ankara, Turkey 2Clinic of Pulmonary Diseases, ARTE Hekimköy Medical Center, Ankara, Turkey 3Department of Chest Diseases, Düzce University School of Medicine, Düzce, Turkey 4Ankara Chamber of Medical Doctors, Commission of Workers’ Health and Occupational Physicians, Ankara, Turkey 5Department of Pulmonary Diseases, Gazi University School of Medicine, Ankara, Turkey 6Clinic of Chest Diseases, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey 7Sleep Disorders Center, Atatürk Chest Diseases, Thoracic Surgery Training and Research Hospital, Ankara, Turkey 8Department of Pulmonary Diseases, Bozok University School of Medicine, Yozgat, Turkey 9Department of Pulmonary Diseases, Ordu University School of Medicine, Ordu, Turkey 10Clinic of Child Chest Diseases, Acıbadem Fulya Hospital, İstanbul, Turkey 11Department of Pulmonary Medicine, İstanbul University İstanbul School of Medicine, İstanbul, Turkey Cite this article as: Ilgaz A, Küçük Uyanusta FÇ, Arbak P, et al. Extensive Exposure to Tear Gases in Ankara. Turk Thorac J 2019; DOI: 10.5152/TurkThoracJ.2018.18096 Abstract OBJECTIVES: The most common chemical substances used as mass control agents are chloroacetophenone, chlorobenzylidene malono- nitrile, and oleoresin capsicum. These agents not only have local and rapid effects but also have systemic and long-term effects. The aim of the present study was to discuss the patterns of tear gas exposure and to investigate its effects on respiratory functions.
    [Show full text]
  • Current Awareness in Clinical Toxicology Editors: Damian Ballam Msc and Allister Vale MD
    Current Awareness in Clinical Toxicology Editors: Damian Ballam MSc and Allister Vale MD April 2015 CONTENTS General Toxicology 9 Metals 44 Management 22 Pesticides 49 Drugs 23 Chemical Warfare 51 Chemical Incidents & 36 Plants 52 Pollution Chemicals 37 Animals 52 CURRENT AWARENESS PAPERS OF THE MONTH Acute toxicity profile of tolperisone in overdose: observational poison centre-based study Martos V, Hofer KE, Rauber-Lüthy C, Schenk-Jaeger KM, Kupferschmidt H, Ceschi A. Clin Toxicol 2015; online early: doi: 10.3109/15563650.2015.1022896: Introduction Tolperisone is a centrally acting muscle relaxant that acts by blocking voltage-gated sodium and calcium channels. There is a lack of information on the clinical features of tolperisone poisoning in the literature. The aim of this study was to investigate the demographics, circumstances and clinical features of acute overdoses with tolperisone. Methods An observational study of acute overdoses of tolperisone, either alone or in combination with one non-steroidal anti-inflammatory drug in a dose range not expected to cause central nervous system effects, in adults and children (< 16 years), reported to our poison centre between 1995 and 2013. Current Awareness in Clinical Toxicology is produced monthly for the American Academy of Clinical Toxicology by the Birmingham Unit of the UK National Poisons Information Service, with contributions from the Cardiff, Edinburgh, and Newcastle Units. The NPIS is commissioned by Public Health England Results 75 cases were included: 51 females (68%) and 24 males (32%); 45 adults (60%) and 30 children (40%). Six adults (13%) and 17 children (57%) remained asymptomatic, and mild symptoms were seen in 25 adults (56%) and 10 children (33%).
    [Show full text]
  • Product Nutritional Analysis
    Product Nutritional Analysis CA Nutri Chemical Analysis Analysis Unit Price (ex VAT) SANAS Accredited? Lead Time Energy by Calculation kJ or kcal No charge if part of Full Nutri Carbohydrate by Calculation g/100g No charge if part of Full Nutri Moisture g/100g R 193 2 Ash g/100g R 193 3 Protein g/100g R 355 3 Glycaemic Carbohydrates g/100g R 1 649 5 Total Sugars g/100g R 1 088 5 (Glucose, Fructose, Sucrose, Lactose and Maltose) Total Fat by AOAC 996.06 g/100g R 950 7 Full Nutritional Fatty acid Composition by AOAC 996.06 g/100g R 1 087 Yes Label of which Saturated g/100g of which Monounsaturated g/100g of which Polyunsaturated g/100g Included as part of Fatty Acid 7 of which Trans Fatty Acids g/100g Composition Omega 3 mg/100g Omega 6 mg/100g Cholesterol mg/100g R 842 7 Total Dietary Fibre by AOAC 985.29 g/100g R 1 636 8 to 12 Sodium mg/100g R 529 5 Salt calculated from Sodium results g/100g No charge if Sodium requested Yes Salt Salt by chloride titration g/100g R 662 Yes 5 Acid Insoluble Ash g/100g R 390 5 to 7 Crude Fibre g/100g R 1 374 Yes 5 to 7 Water Activity - R 527 7 Other pH - R 150 2 Density g/ml R 133 Yes 3 Caffeine mg/100g R 705 Yes 5 Total Capsaicinoids mg/kg R 665 5 (Capsaicin, dihydrocapsaicin, nordihydrocapsaicin and Scoville Heat Value) Antimony (Sb) mg/kg R 813 Arsenic (As) mg/kg R 813 Subc to SGS 10 Calcium (Ca) mg/100g R 529 Chromium (Cr) mg/kg R 813 Copper (Cu) mg/kg R 529 Yes 5 to 7 Iron (Fe) mg/kg R 529 Yes 5 Inorganic Food Testing Potassium (K) mg/100g R 529 Yes 5 Phosphorus (P) mg/kg R 813 Subc 10 Selenium (Se)
    [Show full text]
  • WO 2012/044761 Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date _ . 5 April 2012 (05.04.2012) WO 2012/044761 Al (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 47/48 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, (21) International Application Number: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, PCT/US201 1/053876 DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, 29 September 201 1 (29.09.201 1) KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (25) Filing Language: English NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, (26) Publication Langi English RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, (30) Priority Data: ZM, ZW. 12/893,344 29 September 2010 (29.09.2010) US (84) Designated States (unless otherwise indicated, for every (71) Applicant (for all designated States except US): UNI¬ kind of regional protection available): ARIPO (BW, GH, VERSITY OF NORTH CAROLINA AT WILMING¬ GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, TON [US/US]; 601 South College Road, Wilmington, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, NC 28403 (US).
    [Show full text]
  • Determination of Capsaicinoid Profile of Some Peppers Sold in Nigerian Markets
    Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2014, 6(4):648-654 ISSN : 0975-7384 Research Article CODEN(USA) : JCPRC5 Determination of capsaicinoid profile of some peppers sold in Nigerian markets 1N. C. Nwokem *, 2C. O. Nwokem, 2Y. O. Usman, 1O. J. Ocholi, 2M. L. Batari and 3A. A. Osunlaja 1Department of Chemistry, Ahmadu Bello University, Zaria, Nigeria 2National Research Institute for Chemical Technology, Zaria, Nigeria 3Umar Suleiman College of Education, Gashua, Nigeria ____________________________________________________________________________________________ ABSTRACT The capsaicinoid profile of six different peppers sold in Nigerian markets was determined by Gas Chromatography- Mass Spectrometry. The capsaicinoids were extracted from the peppers using methanol as extractant and analyzed without need for derivatization. A total of eight (8) capsaicinoids were identified and quantitated: Capsaicin, Dihydrocapsaicin Dihydrocapsaicin 1, Dihydrocapsaicin 2, Norcapsaicin, Nordihydrocapsaicin 1, Nordihydrocapsaicin 2 and Nornordihydrocapsaicin though, not fully present in all the varieties. Dihydrocapsaicin 1, Dihydrocapsaicin 2, Nordihydrocapsaicin 1, Nordihydrocapsaicin 2 and Nornordihydrocapsaicin are isomers. Seven were identified in the Cameroun pepper variety, six in “Zaria atarugu” and Miango, and five in each of the remaining varieties. In all the peppers analyzed, capsaicin had the highest relative concentration, which ranged from 27.3% in the Cameroun variety to 49.38% in the “Zaria atarugu” variety. The sum of the relative concentrations of capsaicin and dihydrocapsaicin ranged from 47.03% in the “Miango” variety to 87.3% in the “Zaria atarugu” variety. Keywords: Capsaicinoids, Gas Chromatography-Mass Spectrometry, Methanol, Pepper ____________________________________________________________________________________________ INTRODUCTION Peppers are widely used in many parts of the world as a result of their valued sensory attributes; colour, purgency and aroma.
    [Show full text]
  • And Angiotensin II- Induced Changes by Calcium Antagonists in the Peripheral Circulation Ofanaesthetized Rabbits Robert P
    Br. J. Pharmac. (1985), 85, 75-87 Modification ofvasopressin- and angiotensin II- induced changes by calcium antagonists in the peripheral circulation ofanaesthetized rabbits Robert P. Hof Cardiovascular Unit of Preclinical Research, Sandoz Ltd, CH-4002 Basel, Switzerland 1 Investigations into the site of vasodilator and antivasoconstrictor activity of calcium antagonists previously performed in cats were extended to a second species, barbiturate-anaesthetized rabbits, and a second vasoconstrictor agent, vasopressin. 2 The dihydropyridine derivative darodipine (code name PY 108-068; 10, 30 and 100 pg kg-' i.v.) showed systemic haemodynamic effects comparable to those seen in cats at half these doses. Darodipine effected regional vasodilatation (measured with tracer microspheres) in the heart, brain and skeletal muscles as in cats. Only the vessels of the adrenals (dilated in rabbits but not in cats), and the kidneys and skin (constricted in rabbits but not in cats) responded differently to darodipine. 3 Angiotensin II (A II; 0.15 and 1.5 yg kg- min ')constricted the same vascular beds in rabbits as in cats, namely the heart, kidneys, small intestine, pancreas, spleen, skin and arterio-venous shunts (inferred from microspheres reaching the lungs), the only exceptions being the vessels of the stomach and liver (constriction only in cats) and the adrenals (constriction only in rabbits). 4 Darodipine (30 and 100 yg kg-') attenuated the A II-induced vasoconstriction in the same vascular beds in rabbits as in cats including the kidneys, which were constricted after administration of the antagonist alone. 5 These results indicate surprisingly small species differences for the vasodilator effects of darodipine as well as the attenuation of the vasoconstrictor effects of A II.
    [Show full text]
  • Determination of Capsaicinoids in Peppers by Microwave-Assisted Extraction–High-Performance Liquid Chromatography with fluorescence Detection Gerardo F
    Analytica Chimica Acta 578 (2006) 227–233 Determination of capsaicinoids in peppers by microwave-assisted extraction–high-performance liquid chromatography with fluorescence detection Gerardo F. Barbero, Miguel Palma ∗, Carmelo G. Barroso Grupo de Investigaci´on Qu´ımico Anal´ıtica del Vino y Productos Agroalimentarios, Departamento de Qu´ımica Analitica, Facultad de Ciencias, Universidad de C´adiz, Apartado 40, 11510 Puerto Real, C´adiz, Spain Received 30 March 2006; received in revised form 27 June 2006; accepted 28 June 2006 Available online 4 July 2006 Abstract A new method has been developed for the extraction of capsaicinoids (nordihydrocapsaicin, capsaicin, dihydrocapsaicin, homocapsaicin and homodihydrocapsaicin) in peppers employing microwave-assisted extraction. The parameters studied are: extraction solvent (methanol, ethanol, acetone, ethyl acetate and water), temperature (50–200 ◦C), sample quantity (0.1–1 g), volume of solvent (15–50 mL) and the extraction time (5–20 min). The results found for the optimum conditions are: 125 ◦C as extraction temperature, 25 mL of solvent, 0.5 g of freshly triturated peppers and extraction for 5 min, employing 100% ethanol as solvent. The capsaicinoids obtained were stable under the optimised extraction conditions. The resulting method presents a high degree of reproducibility (R.S.D. < 6%). © 2006 Elsevier B.V. All rights reserved. Keywords: Microwave-assisted extraction; Capsaicinoids; Peppers 1. Introduction Many techniques for the extraction of capsaicinoids from peppers have been studied, such as maceration [9], magnetic stir- Hot or spicy peppers are savoury food additives that are ring [10], Soxhlet [11,12], ultrasound-assisted extraction [13], widely utilised in many parts of the world, and are highly valued extraction by means of supercritical fluids [14], extraction by for their attributes of colour, pungency, and aroma.
    [Show full text]
  • PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
    Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names INN which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service CAS registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known.
    [Show full text]
  • Policing in Ames - a Path Forward
    POLICING IN AMES - A PATH FORWARD September 29, 2020 BACKGROUND: As in other cities throughout the country, after the death of George Floyd while in police custody, the City Council began receiving an extraordinary amount of feedback regarding the manner in which our law enforcement and criminal justice systems are being operated. This input has included questions about policing philosophy and operations as well as suggestions/recommendations/demands to modify how the Ames Police Department functions in those areas. Rather than respond individually to this input over time, the City Council requested that the City Manager compile all the correspondence received, consolidate this information into common themes, and provide recommendations regarding how to address each theme. The following is a list of the common themes: THEME PAGES I. Organizational Culture 2-3 II. Police Officer Recruitment and Selection Process 4-7 III. Police Officer Training/Education 8-10 IV. Departmental Policies 11-23 V. City Ordinances and State Law 24-27 VI. Transparency 28-29 VII. Accountability in Complaint Handling and Discipline 30-37 VIII. Communication 38-39 IX. Funding 40-42 This report is structured to deal with each theme separately, highlighting: 1) What has been suggested, 2) What the City is currently doing in regard to each theme, and 3) the City Manager’s recommendations to address each theme. The recommendations reflected in this report were influenced by the following sources: • Community member suggestions • Police Department staff suggestions • Peer department activities and services • Guidance from the President’s Task Force on 21st Century Policing 1 THEME I – ORGANIZATIONAL CULTURE WHAT HAS BEEN SUGGESTED? Many individuals who provided input wanted to ensure that there is not a culture of racial bias embedded in the Ames Police Department.
    [Show full text]
  • TRP CHANNELS AS THERAPEUTIC TARGETS TRP CHANNELS AS THERAPEUTIC TARGETS from Basic Science to Clinical Use
    TRP CHANNELS AS THERAPEUTIC TARGETS TRP CHANNELS AS THERAPEUTIC TARGETS From Basic Science to Clinical Use Edited by ARPAD SZALLASI MD, PHD Department of Pathology, Monmouth Medical Center, Long Branch, NJ, USA AMSTERDAM • BOSTON • HEIDELBERG • LONDON NEW YORK • OXFORD • PARIS • SAN DIEGO SAN FRANCISCO • SINGAPORE • SYDNEY • TOKYO Academic Press is an imprint of Elsevier Academic Press is an imprint of Elsevier 125 London Wall, London, EC2Y 5AS, UK 525 B Street, Suite 1800, San Diego, CA 92101-4495, USA 225 Wyman Street, Waltham, MA 02451, USA The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, UK First published 2015 Copyright © 2015 Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval system, without permission in writing from the publisher. Details on how to seek permission, further information about the Publisher’s permissions policies and our arrangement with organizations such as the Copyright Clearance Center and the Copyright Licensing Agency, can be found at our website: www.elsevier.com/permissions This book and the individual contributions contained in it are protected under copyright by the Publisher (other than as may be noted herein). Notices Knowledge and best practice in this field are constantly changing. As new research and experience broaden our understanding, changes in research methods, professional practices, or medical treatment may become necessary. Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any information, methods, compounds, or experiments described herein.
    [Show full text]